🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

How long should we wait for response in Ulcerative Colitis? ⏰ Great summary slide by Millie Long ➡️Estimated time for each group ➡️Delayed response can happen!🔗 similar maintenance results as early responders #AIBD2024 @IBDConference Corey Siegel Miguel Regueiro

Outcomes After Dose Intensification of #Risankizumab for #Crohn’s Disease - Clinical Gastroenterology and Hepatology cghjournal.org/article/S1542-… 💊Dose⬆️of risa to q4w or q6w recaptured clin response for 64% of pts with LOR to q8w dosing 💊Dose⬆️of risa➡️clin remission for 45%

Integrated pharmacists can improve ibd care by: ✔️ Immunosuppressive monitoring ✔️Medication Knowledge/ Adherence ✔️Health Promotion and Prevention ✔️Drug Procurement ✔️Therapeutic Drug Monitoring David Choi, PharmD Shubha Bhat, PharmD #AIBD2024 @IBDConference

1️⃣st ever pharmacy track at #AIBD2024 ✅ Thanks to Miguel Regueiro Corey Siegel Millie Long Stephen B. Hanauer, MD @IBDConference for recognizing #PharmD as part of #IBD care teams and for those who came out to provide support for #PharmD education! 🙏

Had a great time presenting on #biosimilars at #ASHP24 alongside 🌟 team: Amanuel Kehasse PharmD, PhD, Alex Mersch, and Kristen Geyer! Some key points of our presentation are highlighted here: news.ashp.org/News/MeetingNe… ASHP Cleveland Clinic

⭐️ Shining a light on Inflammatory Bowel Disease in South Asian populations@southasianIBD When I was diagnosed with Crohn’s disease, it wasn’t thought of as a condition that would impact someone like me, as a person of color or African American. (1/5)

Introducing the 7th FDA #ustekinumab biosimilar: Steqeyma centerforbiosimilars.com/view/fda-appro…

Clinical pharmacists should ideally be part of a multidisciplinary team to improve holistic care of IBD patients 🌸 Clinical Pharmacist Counselling Improves Long-term Medication Safety and Patient-reported Outcomes in Anti-TNF-treated Patients With Inflammatory Bowel Diseases:

💊 IBD Patients Are Rationing Medications Due to Cost & Access Issues. Study: 20.6% skipped prescriptions, 15.2% skipped doses due to insurance & cost barriers. How do we help patients? bit.ly/3QaEU1z #IBD #DrugPricing Shubha Bhat, PharmD Crohn's & Colitis Foundation Susan Kais, MD

Registeration is open for the Mountain State Inflammatory Bowel Disease Symposium. Don't miss this opportunity to connect, learn, and stay updated on the latest in IBD care. Sign up today! #IBD wvumedicine.org/info/mountain-…

#MondayNightIBD Waqqas Afif, MD Shrinivas Bishu Robert Battat MD Jeffrey McCurdy MD PhD valeorillac Seb David Fudman, MD Fernando Gomollón Sara El Ouali MD Waseem Ahmed Joshua M. Steinberg, MD Shubha Bhat, PharmD Sanchu Bhasin 2/ #IBDAlgo #MondayNightIBD Aline Charabaty, MD, FACG, AGAF Phenomenal tweetorial🧵, convos💬 & webinar🎥 on efficacy, safety & role of anti-#IL23p19 in UC & CD ✅Tweetorial & Webinar for review🔗in next tweet ✅Practical info on use of this new MOA👇🏽 Marc Cram Ash Paul ignacio catalan Sophie Restellini

🚀 PharmDs passionate about #IBD care—this one's for you! An opportunity to deepen your expertise with lectures and hands-on clinical rotations. Elevate your impact in patient care and gain real-world experience 🙂 Apply now! DM me with any questions. #PharmD #IBD #MedEd